If you don’t buy the AI bubble fears and think the increased skepticism over some of the names powering the technology, it might be time to get just a bit more greedy to start 2026 off on the right track.
Source: https://247wallst.com/investing/2025/12/26/2-cheaper-ai-stoc…
Lemonade, Moelis, and Bank of Montreal are showing constructive technical setups.
Nvidia remains well positioned to benefit from the AI infrastructure buildout. Broadcom has a huge opportunity in front of it with custom AI chips.
Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.
